Apimeds Pharmaceuticals US reported total assets of $127.62M and total liabilities of $21.18M for the quarter ended Jun 2026. This balance sheet covers 10 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.01M | 0.01M | ||||||||
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash & EquivalentsCash & Equiv. | 0.41M | 0.00M | 0.25M | 8.74M | 6.99M | 149.89M | 116.74M | |||
| Receivables - OtherOther Receivables | 3.00M | |||||||||
| Prepaid Assets | 0.01M | 0.01M | 0.01M | 1.61M | 2.10M | 2.30M | 2.24M | |||
| Current Assets | 0.42M | 0.01M | 0.26M | 10.35M | 9.09M | 13.98M | 10.68M | |||
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment (Net) | 0.01M | 0.03M | 0.05M | 0.05M | ||||||
| Intangibles | 149.89M | 116.74M | ||||||||
| Goodwill & Intangibles | 149.89M | 116.74M | ||||||||
| Other Non-Current Assets | 0.18M | 0.13M | 0.08M | 33.15M | ||||||
| Non-Current Assets | 0.20M | 0.16M | 150.20M | 116.95M | ||||||
| Assets | 0.42M | 0.01M | 0.26M | 10.55M | 9.25M | 164.18M | 127.62M | |||
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payables | 0.05M | 0.59M | 0.94M | 0.12M | 0.57M | |||||
| Notes Payables | 0.27M | 0.25M | 0.37M | 7.09M | 8.91M | |||||
| Payables | 0.32M | 0.84M | 1.31M | 0.12M | 0.57M | 7.09M | 8.91M | |||
| Accumulated Expenses | 0.07M | 0.59M | 0.12M | 0.92M | 3.22M | |||||
| Other Accumulated Expenses | 0.08M | 0.09M | 100.00 | 100.00 | ||||||
| Current Leases | 0.04M | 0.06M | ||||||||
| Total Current Liabilities | 0.12M | 1.02M | 1.77M | 0.81M | 1.09M | 10.71M | 21.07M | |||
| Non-Current Liabilities | ||||||||||
| Non-Current Debt | 0.25M | 5.00M | ||||||||
| Convertible Debt | 0.35M | 0.24M | 0.24M | |||||||
| Operating Leases | 0.13M | 0.10M | ||||||||
| Other Non-Current Liabilities | 0.07M | 0.17M | 1.62M | 1.35M | ||||||
| Total Non-Current Liabilities | 0.32M | 0.63M | 9.22M | 19.82M | ||||||
| Total Liabilities | 0.39M | 0.26M | 0.71M | 1.05M | 1.37M | 2.02M | 0.81M | 1.09M | 10.84M | 21.18M |
| Shareholder's Equity | ||||||||||
| Total Debt | 0.27M | 0.25M | 0.62M | 7.09M | 13.91M | |||||
| Common Equity | 0.03M | -0.26M | -0.71M | -1.05M | -1.36M | -1.76M | 9.74M | 8.16M | 153.35M | 106.45M |
| Liabilities and Shareholders Equity | 0.42M | 0.01M | 0.26M | 10.55M | 9.25M | 164.18M | 127.62M | |||
| Retained Earnings | -3.00M | -4.39M | -4.79M | 17.07M | 17.27M | 163.74M | 168.44M | |||
| Preferred Shares | 748.00 | 748.00 |